Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Treasury Shares (2022 - 2024)

Adial Pharmaceuticals' Treasury Shares history spans 3 years, with the latest figure at $4.2 million for Q3 2024.

  • For Q3 2024, Treasury Shares changed N/A year-over-year to $4.2 million; the TTM value through Sep 2024 reached $4.2 million, changed N/A, while the annual FY2023 figure was $4.2 million, 767.84% up from the prior year.
  • Treasury Shares for Q3 2024 was $4.2 million at Adial Pharmaceuticals, roughly flat from $4.2 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $4.2 million in Q1 2024 and bottomed at $168929.0 in Q4 2023.
  • The 3-year median for Treasury Shares is $4.2 million (2024), against an average of $2.7 million.
  • The largest YoY upside for Treasury Shares was 65.29% in 2023 against a maximum downside of 65.29% in 2023.
  • A 3-year view of Treasury Shares shows it stood at $486726.0 in 2022, then tumbled by 65.29% to $168929.0 in 2023, then surged by 2387.18% to $4.2 million in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Treasury Shares are $4.2 million (Q3 2024), $4.2 million (Q2 2024), and $4.2 million (Q1 2024).